BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7913672)

  • 41. Diagnosis of haemophilia B using the polymerase chain reaction.
    Reiss J; Neufeldt U; Wieland K; Zoll B
    Blut; 1990 Jan; 60(1):31-6. PubMed ID: 1967542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factor IX gene haplotypes in Brazilian blacks and characterization of unusual DdeI alleles.
    Figueiredo MS; Bowen DJ; Silva Júnior WA; Zago MA
    Br J Haematol; 1994 Aug; 87(4):789-96. PubMed ID: 7986720
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe haemophilia B due to a 6 kb factor IX gene deletion including exon 4: non-homologous recombination associated with a shortened transcript from whole blood.
    Hsu TC; Nakaya SM; Thompson AR
    Thromb Haemost; 2007 Feb; 97(2):176-80. PubMed ID: 17264943
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Carrier and prenatal diagnostic strategy and newly identified mutations in Hungarian haemophilia A and B families.
    Bors A; Andrikovics H; Illés Z; Jáger R; Kardos M; Marosi A; Nemes L; Tordai A
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):161-6. PubMed ID: 25255241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The use of DNA amplification for genetic counselling related diagnosis in haemophilia B.
    Tsang TC; Bentley DR; Nilsson IM; Giannelli F
    Thromb Haemost; 1989 Jun; 61(3):343-7. PubMed ID: 2572072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Twenty-four novel hemophilia B mutations revealed by rapid scanning of the whole factor IX gene in a French population sample.
    Ghanem N; Costes B; Martin J; Vidaud M; Rothschild C; Foyer-Gazengel C; Goossens M
    Eur J Hum Genet; 1993; 1(2):144-55. PubMed ID: 8055323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factor IX gene polymorphisms in Indian population.
    Chowdhury MR; Kabra M; Menon PS
    Am J Hematol; 2001 Dec; 68(4):246-8. PubMed ID: 11754413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of factor IX allotypes for carrier identification in haemophilia B.
    Wallmark A; Ljung R; Nilsson IM
    Br J Haematol; 1987 Dec; 67(4):427-32. PubMed ID: 3426960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of a new haemophilia BM case produced by a mutation located at the carboxy terminal cleavage site of activation peptide.
    Solera J; Magallón M; Martin-Villar J; Coloma A
    Br J Haematol; 1991 Jul; 78(3):385-9. PubMed ID: 1651755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A factor IX gene probe: its use in carrier detection, antenatal diagnosis and characterisation of the molecular basis for hemophilia B.
    Trent RJ; Svirklys L; Power PA; Rickard KA; Lammi A; Kronenberg H
    Aust N Z J Med; 1985 Dec; 15(6):721-6. PubMed ID: 3869438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of a BamHI polymorphism in the factor IX gene for the determination of hemophilia B carrier status.
    Hay CW; Robertson KA; Yong SL; Thompson AR; Growe GH; MacGillivray RT
    Blood; 1986 May; 67(5):1508-11. PubMed ID: 3008893
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A past mutation at isoleucine 397 is now a common cause of moderate/mild haemophilia B.
    Bottema CD; Koeberl DD; Ketterling RP; Bowie EJ; Taylor SA; Lillicrap D; Shapiro A; Gilchrist G; Sommer SS
    Br J Haematol; 1990 Jun; 75(2):212-6. PubMed ID: 2372508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single nucleotide polymorphisms of the factor IX gene for linkage analysis in the southern Chinese population.
    Chan V; Yam I; Yip B; Au P; Shing MK; Li CK; Chan TK
    Br J Haematol; 2000 Nov; 111(2):540-3. PubMed ID: 11122097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms.
    Winship PR; Anson DS; Rizza CR; Brownlee GG
    Nucleic Acids Res; 1984 Dec; 12(23):8861-72. PubMed ID: 6096810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Genetic diagnosis in haemophiliacs (haemophilia A, B, carrier)].
    Mikami S
    Rinsho Byori; 1990 Jun; Suppl 85():102-13. PubMed ID: 1976834
    [No Abstract]   [Full Text] [Related]  

  • 57. A codon 338 nonsense mutation in the factor IX gene in unrelated hemophilia B patients: factor IX338 New York.
    Driscoll MC; Bouhassira E; Aledort LM
    Blood; 1989 Aug; 74(2):737-42. PubMed ID: 2752145
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consequences of factor IX mutations in 26 families with haemophilia B.
    Weinmann AF; Murphy ME; Thompson AR
    Br J Haematol; 1998 Jan; 100(1):58-61. PubMed ID: 9450791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T296----M, a common mutation causing mild hemophilia B in the Amish and others: founder effect, variability in factor IX activity assays, and rapid carrier detection.
    Ketterling RP; Bottema CD; Koeberl DD; Ii S; Sommer SS
    Hum Genet; 1991 Jul; 87(3):333-7. PubMed ID: 1864609
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carrier detection of haemophilia B by using an intragenic restriction-fragment length polymorphism.
    Bröcker-Vriends AH; Briët E; Quadt R; Bertina RM; van der Linden IK; van de Kamp JJ; Pearson PL; Veltkamp JJ
    Thromb Haemost; 1985 Aug; 54(2):506-9. PubMed ID: 3001965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.